Kodai Kunisada - Japanese Red Cross Medical Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada, Moe Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki,Tadao Ishida

HEMATOLOGICAL ONCOLOGYno. 1 (2024): e3248-e3248

引用0浏览0WOS引用

Prognostic Impact of 1q Abnormality on Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide and Dexamethasone in a Real-World Clinical Setting

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada, Chiaki Matsumoto,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki, Osamu Hosoya,Tadao Ishida

Annals of Hematologypp.1-3, (2024)

引用0浏览0WOS引用

Cytomegalovirus Reactivation During Elotuzumab Therapy in Patients with Multiple Myeloma

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki,Tadao Ishida

Acta haematologica（2024）

引用0浏览0WOS引用

Cytomegalovirus Infection During Daratumumab Therapy in Patients with Newly Diagnosed Multiple Myeloma

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki,Tadao Ishida

International journal of hematology (2024)

引用0浏览0WOS引用

Prognostic Value of the "dynamic" R2-ISS in Patients with Multiple Myeloma Undergoing Anti-Cd38 Antibody-Based Triplet Therapies

Taku Kikuchi,Yuki Oda, Ukyo Kondo,Nobuhiro Tsukada,Kodai Kunisada, Chiaki Matsumoto,Moe Nomura-Yogo,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki, Osamu Hosoya,Tadao Ishida

HEMATOLOGICAL ONCOLOGYno. 5 (2024)

引用0浏览0WOS引用

Author Response for "prognostic Value of the Second Revision of the International Staging System (R2‐ISS) in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation"

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada, Makiko Yogo, Yoshiko Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki,Tadao Ishida

Hematological oncologyno. 1 (2024)

引用0浏览0引用

Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real-world clinical setting

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada, Chiaki Matsumoto,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe, Kenshi Suzuki, Osamu Hosoya,Tadao Ishida

Hematological oncologyno. 5 (2024): e3306-e3306

引用0浏览0WOS引用

[Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma after Myeloablative Conditioning with 8 Gy of Total Body Irradiation]

Nobuhiro Tsukada, Moe Yogo,Kodai Kunisada,Yuki Oda,Tomomi Takei,Kota Sato,Mizuki Ogura,Taku Kikuchi,Yu Abe,Kenshi Suzuki,Tadao Ishida

Rinsho ketsueki The Japanese journal of clinical hematologyno. 7 (2024): 615-621

引用0浏览0WOS引用

Prognostic Value of the “dynamic” Second Revision of the International Staging System (R2- ISS) in Patients with Multiple Myeloma Undergoing Anti-Cd38 Antibody, Carfilzomib, and Dexamethasone Therapy

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada, Chiaki Matsumoto,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki, Osamu Hosaya,Tadao Ishida

crossref（2024）

引用0浏览0引用

Real-world Clinical Outcomes in Patients with Relapsed and Refractory Multiple Myeloma Receiving VTD-PACE Treatment in the Era of Monoclonal Antibodies

Taku Kikuchi,Nobuhiro Tsukada,Kodai Kunisada,Moe Nomura-Yogo,Yuki Oda,Kota Sato,Tomomi Takei,Mizuki Ogura,Yu Abe,Kenshi Suzuki,Tadao Ishida

Annals of hematology（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn